Internal Medicine, Hematology & Oncology · St. Paul, MN
NPI
1861618373
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
640 Jackson St, Healthpartners Regions Specialty Clinics - Mc 11503f
St. Paul, MN, 55101
Phone (651) 254-3448
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
704 services
Medicare patients, 2024
159
Average age 72
Drug cost, 2024
$3.6M
1,479 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven E McCormack was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 135 times for 89 patients. In total Steven E McCormack billed 704 services in 22 codes, and Medicare paid $31K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 135 | 89 | $12.07 | $1,630 |
| 99215 Office E&M - Established | Facility | 118 | 43 | $104.73 | $12K |
| 99214 Office E&M - Established | Facility | 108 | 78 | $62.84 | $6,787 |
| 36415 Venipuncture Blood Collection | Office | 93 | 40 | $8.56 | $796 |
| 85025 Blood Count | Office | 90 | 33 | $7.55 | $680 |
| 82565 Clinical Chemistry | Office | 35 | 26 | $4.92 | $172 |
| 99205 Office E&M - New | Facility | 22 | 22 | $123.07 | $2,707 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 12 | $89.19 | $1,695 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $130.29 | $1,954 |
By year: 2022 $31K for 624 services; 2023 $28K for 492 services; 2024 $31K for 704 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 93 | 40 | $8.56 | $796 |
| 85025 Blood Count | 90 | 33 | $7.55 | $680 |
| 82565 Clinical Chemistry | 35 | 26 | $4.92 | $172 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven E McCormack prescribed most often to Medicare patients was Anastrozole, with 156 prescriptions and refills. In total Steven E McCormack wrote 1,479 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 156 | 438 | 50 | $2,994 |
| Oxycodone Hcl Generic | 86 | 86 | 20 | $1,356 |
| Dexamethasone Generic | 67 | 67 | 24 | $596 |
| Letrozole Generic | 56 | 132 | 15 | $1,189 |
| Olanzapine Generic | 51 | 57 | 20 | $286 |
| Morphine Sulfate Er Morphine Sulfate | 44 | 44 | Under 11 | $1,308 |
| Prochlorperazine Maleate Generic | 43 | 43 | 31 | $861 |
| Ondansetron Hcl Generic | 41 | 41 | 28 | $366 |
| Imbruvica Ibrutinib | 36 | 36 | Under 11 | $727K |
| Gabapentin Generic | 30 | 65 | Under 11 | $445 |
| Calquence Acalabrutinib Maleate | 29 | 29 | Under 11 | $452K |
| Hydroxyurea Generic | 29 | 82 | Under 11 | $1,100 |
| Abiraterone Acetate Generic | 29 | 31 | Under 11 | $17K |
| Acyclovir Generic | 28 | 70 | Under 11 | $912 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 55 | Under 11 | $198 |
Brand drugs: 263 claims; generic drugs: 1,216 claims; opioid claims: 204.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven E McCormack $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.